SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-026136
Filing Date
2022-05-13
Accepted
2022-05-13 07:30:53
Documents
82
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0322_inmedpharma.htm   iXBRL 10-Q 870300
2 CERTIFICATION f10q0322ex31-1_inmedpharma.htm EX-31.1 15743
3 CERTIFICATION f10q0322ex31-2_inmedpharma.htm EX-31.2 16035
4 CERTIFICATION f10q0322ex32-1_inmedpharma.htm EX-32.1 4601
5 CERTIFICATION f10q0322ex32-2_inmedpharma.htm EX-32.2 3080
6 GRAPHIC image_001.jpg GRAPHIC 12869
  Complete submission text file 0001213900-22-026136.txt   5006363

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE inm-20220331.xsd EX-101.SCH 75497
8 XBRL CALCULATION FILE inm-20220331_cal.xml EX-101.CAL 28742
9 XBRL DEFINITION FILE inm-20220331_def.xml EX-101.DEF 250285
10 XBRL LABEL FILE inm-20220331_lab.xml EX-101.LAB 525754
11 XBRL PRESENTATION FILE inm-20220331_pre.xml EX-101.PRE 262528
76 EXTRACTED XBRL INSTANCE DOCUMENT f10q0322_inmedpharma_htm.xml XML 540776
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-39685 | Film No.: 22920245
SIC: 2834 Pharmaceutical Preparations